Evidence map›Paper›PMID 36595686›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Sec22b is a critical and nonredundant regulator of plasma cell maintenance.

Amélie Bonaud, Laetitia Gargowitsch, Simon M Gilbert, Elanchezhian Rajan, Pablo Canales-Herrerias, Daniel Stockholm, Nabila F Rahman, Mark O Collins, Hakan Taskiran, Danika L Hill and 15 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. CRISPRi Screen Identifies a Novel Growth Suppressor lncRNA,bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 5 countries.

Amélie BonaudUniversité Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.ORCID 0000-0002-4153-9171
Laetitia GargowitschUniversité Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France.
Simon M GilbertDepartment of Medicine, University of Cambridge, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.
Elanchezhian RajanSchool of Bioscience, University of Sheffield, Sheffield S102TN, UK.ORCID 0000-0002-6257-3678
Pablo Canales-HerreriasUnit of Antibodies in Therapy and Pathology, Institut Pasteur, Université de Paris, INSERM UMR1222, F-75015 Paris, France.ORCID 0000-0002-1865-6476
Daniel StockholmPSL Research University, EPHE, 75014 Paris, France.ORCID 0000-0002-5069-5256
Nabila F RahmanDementia Research Institute, University of Cardiff, Cardiff CF24 4HQ, UK.
Mark O CollinsSchool of Bioscience, University of Sheffield, Sheffield S102TN, UK.ORCID 0000-0002-7656-4975
Hakan TaskiranInstitute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich 81675, Germany.ORCID 0000-0002-2690-3887
Danika L HillLymphocyte Signalling and Development, Babraham Institute, Cambridge CB22 3AT, UK.
Andres AlloattiPSL Research University, Institut Curie Research Center, INSERM U932, 75005 Paris, France.ORCID 0000-0003-0555-0653
Nagham AloucheUniversité Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France.
Stéphanie BalorMETi, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 31062, Toulouse, France.
Vanessa SoldanMETi, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 31062, Toulouse, France.
Daniel GilletUniversité Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, SIMoS, Gif-sur-Yvette 91191, France.ORCID 0000-0003-0477-3599
Julien BarbierUniversité Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, SIMoS, Gif-sur-Yvette 91191, France.
Françoise BachelerieUniversité Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France.
Kenneth G C SmithDepartment of Medicine, University of Cambridge, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.
Julia JellusovaInstitute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich 81675, Germany.
Pierre BruhnsUnit of Antibodies in Therapy and Pathology, Institut Pasteur, Université de Paris, INSERM UMR1222, F-75015 Paris, France.ORCID 0000-0002-4709-8936
Sebastian AmigorenaPSL Research University, Institut Curie Research Center, INSERM U932, 75005 Paris, France.
Karl BalabanianUniversité Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.ORCID 0000-0002-0534-3198
Michelle A LintermanLymphocyte Signalling and Development, Babraham Institute, Cambridge CB22 3AT, UK.ORCID 0000-0001-6047-1996
Andrew A PedenSchool of Bioscience, University of Sheffield, Sheffield S102TN, UK.ORCID 0000-0003-0144-7712
Marion EspéliUniversité Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.ORCID 0000-0001-5005-1664
Inserm · FRCentre National de la Recherche Scientifique · FRUniversity of Sheffield · GBBabraham Institute · GBCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRUniversity of Cambridge · GBConsejo Nacional de Investigaciones Científicas y Técnicas · ARMax Planck Institute of Immunobiology and Epigenetics · DETechnical University of Munich · DEUK Dementia Research Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L022389/1Biotechnology and Biological Sciences Research Council BBS/E/B/000C0427Biotechnology and Biological Sciences Research Council BBS/E/B/000C0428Wellcome TrustWellcome Trust 083650/Z/07/Z
6 · The paper itself

Abstract

Despite the essential role of plasma cells in health and disease, the cellular mechanisms controlling their survival and secretory capacity are still poorly understood. Here, we identified the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) Sec22b as a unique and critical regulator of plasma cell maintenance and function. In the absence of Sec22b, plasma cells were hardly detectable and serum antibody titers were dramatically reduced. Accordingly,

Indexed as

Plasma CellsSNARE ProteinsAnimalsBiological TransportEndoplasmic ReticulumMiceR-SNARE ProteinsR-SNARE ProteinsSec22b protein, mouseSNARE Proteinsantibodyendoplasmic reticulummitochondriaplasma cellSNARE

Identifiers

PMID36595686
PMCPMC9926242
OpenAlexW4313528059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.